Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Revenue

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Net Sales ₹263 Cr₹224 Cr₹220 Cr₹185 Cr₹184 Cr

What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?

The latest Revenue ratio of SYNCOM FORMULATIONS (INDIA) is ₹263 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹263 Cr
Mar2023₹224 Cr
Mar2022₹220 Cr
Mar2017₹185 Cr
Mar2016₹184 Cr

How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?

Years Revenue % Change
Mar2024 ₹263 Cr
17.45
Mar2023 ₹224 Cr
2.09
Mar2022 ₹220 Cr
18.85
Mar2017 ₹185 Cr
0.50
Mar2016 ₹184 Cr -

Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,706.1 Cr -1.3% -5.7% 18.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹123,675.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 1.4% -3.3% -7.2% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-1.3%

-5.7%

18.4%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses